Results 211 to 220 of about 23,539 (262)

Model‐Informed Evaluation of Hydroxyurea Exposure During Lactation

Clinical Pharmacology &Therapeutics, EarlyView.
Hydroxyurea is a cornerstone therapy for sickle cell anemia; however, evidence guiding its use during lactation remains limited. This study aimed to develop a population pharmacokinetic (PK) model to characterize hydroxyurea disposition in maternal plasma and breast milk, and to quantify infant exposure under clinically relevant breastfeeding scenarios.
Anhar Hosawi, Kei Irie, Min Dong, Julie Ware, Russell Ware, Tomoyuki Mizuno   +5 more
wiley   +1 more source

Vascular Health and Early Atherosclerosis in Childhood Cancer Survivors: Reassuring Findings From Comprehensive Noninvasive Assessment. [PDF]

JACC Adv
Fournier E, Joye R, Pozza A, Hui W, Friedberg MK, Lam E, Runeckles K, Signorile M, Fan S, McCrindle B, Mertens L, Nathan PC.   +11 more
europepmc   +1 more source

Altered Neuroretinal Tissue in Childhood Cancer Survivors: Data From the German CVSS Study. [PDF]

Transl Vis Sci Technol
Schuster AK, Welzel AM, Jäger T, Nickels S, Schulz A, Faber J, Merzenich H, Schmidtmann I, Münzel T, Lackner KJ, Beutel ME, Pfeiffer N, Wild PS.   +12 more
europepmc   +1 more source

Illness Perceptions and Quality of Life in Childhood Cancer Survivors. [PDF]

Cancers (Basel)
Kohút A, Koutná V, Blatný M, Jelínek M.   +3 more
europepmc   +1 more source

Sexual Experience, Psychological Implications, and Typical Response Strategies Among Childhood Cancer Survivors With Sexual Dysfunction in China: A Qualitative Study. [PDF]

Psychooncology
Yang F, Ho KY, Ji Y, Zhai Y, Zuo W, Liu X, Wang L, Wai Lam KK, Liu Q, Mao T, Tsoi Cheng FW, Fai NGC, Shi H, Wang Q, Wong FK, Yorke J.   +15 more
europepmc   +1 more source

Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step Approach. [PDF]

Cancers (Basel)
Guida F, Fabi M, Balducci A, Zama D, Masetti R, Mercolini F, Belotti T, Cantarini ME, Facchini E, Legnani EL, Melchionda F, Bartolacelli Y, Ciuca C, Gesuete V, Prete A, Donti A, Lanari M.   +16 more
europepmc   +1 more source

Adult Growth Hormone Deficiency, Replacement Therapy, and Outcomes in Long-Term Childhood Cancer Survivors. [PDF]

J Clin Endocrinol Metab
Yoshida T, Baedke JL, Wang H, Chen Y, Yu C, Wilson CL, Mulrooney DA, Dixon SB, Huang IC, Brinkman TM, Krull KR, Mostoufi-Moab S, Martínez JM, Ness KK, Hudson MM, Yasui Y, Delaney A.   +16 more
europepmc   +1 more source

Eligibility for Cochlear Implant Candidacy Evaluation in Childhood Cancer Survivors.

JAMA Oncol
Bass JK, Warren SE, Dillard SG, Peeples AL, Li K, Jones S, Hua CH, Xie L, Liu S, Ness KK, Hudson MM, Armstrong GT, Richard C, Krull KR.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiometabolic risk in childhood cancer survivors

Minerva Pediatrics, 2022
The Italian Cancer Registry Association has estimated that for the five-year period 2016-2020, in line with the previous five years, approximately 7000 neoplasms have been diagnosed among children and 4000 among adolescents. Leukemias, brain tumors and lymphomas together account for more than two-thirds of all pediatric cancers.
Luongo C., Randazzo E., Iughetti L., Di iorgi N., Loche S., Maghnie M., Valerio G., Delvecchio M.   +7 more
openaire   +2 more sources